.Pharmacolibrary.Drugs.N_NervousSystem.N05C_HypnoticsAndSedatives.N05CH03_Tasimelteon.Tasimelteon

Information

name:Tasimelteon
ATC code:N05CH03
route:oral
n-compartments1

Tasimelteon is a melatonin receptor agonist targeting MT1 and MT2 receptors, approved for the treatment of non-24-hour sleep-wake disorder (Non-24), primarily in totally blind adults. It is also investigated for circadian rhythm sleep disorders. The drug is currently approved and in use.

Pharmacokinetics

Healthy adult volunteers; oral administration; single and repeated doses.

References

    Revisions

    Generated at 2025-07-21T18:21:10Z by OpenModelicaOpenModelica 1.25.1 using GenerateDoc.mos